Home › NDC Lookup › Labelers › Patheon Italia S.p.a.

Patheon Italia S.p.a. NDCs and Package Codes

This page lists NDC package records associated with labeler code 68225 (Patheon Italia S.p.a.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

100
Package NDCs
89
Products
89
Active listings
0
Discontinued
56
Ingredients
0
Therapeutic classes
9
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
EFMOROCTOCOG ALFA 10
rusfertide 5
IOPAMIDOL 4
coagulation factor IX (recombinant... 4
ustekinumab-ttwe 3
RISANKIZUMAB 3
romiplostim 3
teduglutide 2
Basiliximab 2
ustekinumab-stba 2
By dosage form
INJECTION, POWDER, LYOPHILIZED, FO... 40
INJECTION, SOLUTION 21
POWDER, FOR SOLUTION 12
INJECTION 7
POWDER 3
INJECTION, SOLUTION, CONCENTRATE 2
INJECTION, POWDER, FOR SOLUTION 2
KIT 1

Browse records — 89 products

Drug / product Billing NDC NADAC / unit Status
Abatacept 250 mg/15mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0241-00 · 154 VIAL, SINGLE-USE in 1 BOX (68225-241-00) / 15 mL in 1 VIAL, SINGLE-USE 68225-0241-00 — On market View →
Anakinra 100 mg/.67mL INJECTION, SOLUTION Patheon · NDC 68225-0067-00 · 21120 SYRINGE, GLASS in 1 CONTAINER (68225-067-00) / .67 mL in 1 SYRINGE, GLASS 68225-0067-00 — On market View →
apomorphine hydrochloride 4.9 mg/mL INJECTION, SOLUTION Patheon · NDC 68225-0254-00 · 480 CARTRIDGE in 1 BOX (68225-254-00) / 20 mL in 1 CARTRIDGE 68225-0254-00 — On market View →
Basiliximab 10 mg/2.5mL INJECTION, POWDER, FOR SOLUTION Patheon · NDC 68225-0237-00 · 2232 VIAL, GLASS in 1 BOX (68225-237-00) / 2.5 mL in 1 VIAL, GLASS 68225-0237-00 — On market View →
Basiliximab 20 mg/5mL INJECTION, POWDER, FOR SOLUTION Patheon · NDC 68225-0238-00 · 2232 VIAL, GLASS in 1 BOX (68225-238-00) / 2.5 mL in 1 VIAL, GLASS 68225-0238-00 — On market View →
bivalirudin 250 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0041-00 · 27540 VIAL in 1 CONTAINER (68225-041-00) / 5 mL in 1 VIAL 68225-0041-00 — On market View →
brodalumab 210 mg/1 INJECTION Patheon · NDC 68225-0086-00 · 14688 SYRINGE in 1 CONTAINER (68225-086-00) / 1 INJECTION in 1 SYRINGE 68225-0086-00 — On market View →
Cangrelor 50 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0062-01 · 19278 VIAL, SINGLE-USE in 1 CONTAINER (68225-062-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE 68225-0062-01 — On market View →
caplacizumab 11 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0256-00 · 126 CARTON in 1 CONTAINER (68225-256-00) / 247 VIAL in 1 CARTON / 2 mL in 1 VIAL 68225-0256-00 — On market View →
certolizumab pegol 200 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0045-01 · 21000 VIAL in 1 CONTAINER (68225-045-01) / 1 mL in 1 VIAL 68225-0045-01 — On market View →
Coagulation factor ix (recombinant) 3000 [iU]/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0242-00 · 144 VIAL in 1 TRAY (68225-242-00) / 5 mL in 1 VIAL 68225-0242-00 — On market View →
coagulation factor IX (recombinant) 500 [iU]/5mL POWDER Patheon · NDC 68225-0059-00 · 1152 VIAL in 1 CONTAINER (68225-059-00) / 5 mL in 1 VIAL 68225-0059-00 — On market View →
coagulation factor IX (recombinant) 1000 [iU]/5mL POWDER Patheon · NDC 68225-0060-00 · 1152 VIAL in 1 CONTAINER (68225-060-00) / 5 mL in 1 VIAL 68225-0060-00 — On market View →
coagulation factor IX (recombinant) 1500 [iU]/5mL POWDER Patheon · NDC 68225-0061-00 · 1152 VIAL in 1 CONTAINER (68225-061-00) / 5 mL in 1 VIAL 68225-0061-00 — On market View →
Daptomycin 500 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0082-01 · 96 BOX in 1 CONTAINER (68225-082-01) / 108 VIAL, SINGLE-USE in 1 BOX / 10 mL in 1 VIAL, SINGLE-USE 68225-0082-01 — On market View →
Daptomycin 500 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Patheon · NDC 68225-0052-01 · 10368 VIAL in 1 CONTAINER (68225-052-01) / 10 mL in 1 VIAL 68225-0052-01 — On market View →
DEFIBROTIDE SODIUM 80 mg/mL INJECTION, SOLUTION Patheon · NDC 68225-0107-00 · 24 VIAL, GLASS in 1 CASE (68225-107-00) / 2.5 mL in 1 VIAL, GLASS 68225-0107-00 — On market View →
delafloxacin meglumine 300 mg/10.5mL POWDER, FOR SOLUTION Patheon · NDC 68225-0099-00 · 81 TRAY in 1 CONTAINER (68225-099-00) / 70 VIAL in 1 TRAY / 10.5 mL in 1 VIAL 68225-0099-00 — On market View →
denosumab-bmwo 120 mg/1.7mL INJECTION Patheon · NDC 68225-0271-00 · 247 VIAL, SINGLE-USE in 1 BOX (68225-271-00) / 1.7 mL in 1 VIAL, SINGLE-USE 68225-0271-00 — On market View →
DIFELIKEFALIN ACETATE 50 ug/mL INJECTION Patheon · NDC 68225-0122-00 · 247 VIAL, SINGLE-USE in 1 CONTAINER (68225-122-00) / 1.5 mL in 1 VIAL, SINGLE-USE 68225-0122-00 — On market View →
eculizumab 300 mg/30mL INJECTION, SOLUTION, CONCENTRATE Patheon · NDC 68225-0042-00 · 5184 VIAL in 1 CONTAINER (68225-042-00) / 30 mL in 1 VIAL 68225-0042-00 — On market View →
EFMOROCTOCOG ALFA 500 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0090-00 · 32 CASE in 1 CONTAINER (68225-090-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0090-00 — On market View →
EFMOROCTOCOG ALFA 1500 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0093-00 · 32 CASE in 1 CONTAINER (68225-093-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0093-00 — On market View →
EFMOROCTOCOG ALFA 2000 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0094-00 · 32 CASE in 1 CONTAINER (68225-094-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0094-00 — On market View →
EFMOROCTOCOG ALFA 3000 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0095-00 · 32 CASE in 1 CONTAINER (68225-095-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0095-00 — On market View →
EFMOROCTOCOG ALFA 6000 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0098-00 · 32 CASE in 1 CONTAINER (68225-098-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0098-00 — On market View →
EFMOROCTOCOG ALFA 250 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0089-00 · 32 CASE in 1 CONTAINER (68225-089-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0089-00 — On market View →
EFMOROCTOCOG ALFA 1000 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0092-00 · 32 CASE in 1 CONTAINER (68225-092-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0092-00 — On market View →
EFMOROCTOCOG ALFA 750 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0091-00 · 32 CASE in 1 CONTAINER (68225-091-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0091-00 — On market View →
EFMOROCTOCOG ALFA 4000 [iU]/3mL POWDER, FOR SOLUTION Patheon · NDC 68225-0096-00 · 32 CASE in 1 CONTAINER (68225-096-00) / 4 TRAY in 1 CASE / 108 VIAL in 1 TRAY / 10 mL in 1 VIAL 68225-0096-00 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.